RB1 and glioma: Therefore, taking advantage of an oncogenic Ras expression and Rb inactivation-based in vitro model of gliomagenesis, as previously reported [12], we explored whether these specific genetic alterations induce a cell phenotype compatible with glioma cell evasion from NK cell-mediated cytotoxicity.